Skip to main content
Erschienen in: Pediatric and Developmental Pathology 4/2005

01.08.2005 | Original Article

Cutaneovisceral Angiomatosis With Thrombocytopenia

verfasst von: Vinay Prasad, Steven J. Fishman, John B. Mulliken, Victor L. Fox, Marilyn G. Liang, Giannoula Klement, Mark W. Kieran, Patricia E. Burrows, David A. Waltz, Julie Powell, Josée Dubois, Moise L. Levy, Antonio R. Perez-Atayde, Harry P.W. Kozakewich

Erschienen in: Pediatric and Developmental Pathology | Ausgabe 4/2005

Einloggen, um Zugang zu erhalten

Abstract

We describe 10 children with multiple vascular lesions of the skin and gastrointestinal tract associated with sustained, minor thrombocytopenia. In some children, there was involvement of the lung (n = 5), bone (n = 2), liver (n = 1), spleen (n = 1), and muscle (n = 1). The cutaneous lesions were congenital, multifocal, discrete, red-brown and variably blue macules and papules; in 3 children, a large dominant plaque was also present. All children developed hematemesis and/or melena and endoscopic evaluation revealed several to numerous small mucosal lesions that involved all levels of the gastrointestinal tract. Three of 5 children with pulmonary nodules had cough and 1 also had hemoptysis. Biopsies of cutaneous, gastrointestinal, and pulmonary lesions showed thin-walled, blood-filled vascular channels and variable endothelial hyperplasia. The endothelial nuclei were elongated, round, crescentic, or hobnailed. Cytoplasmic and extracellular periodic acid-Schiff positive deposits were often present in the zones of endothelial hyperplasia. The platelets were small in some children, suggesting a primary defect, possibly accounting for the thrombocytopenia. Gastrointestinal hemorrhage and hemoptysis required antiangiogenic therapy. The constellation of findings defines a congenital proliferative disorder of blood vessels with a distinctive microscopic appearance. We have termed this relatively indolent or slowly progressive disorder cutaneovisceral angiomatosis with thrombocytopenia because this designation incorporates its major clinical and histopathologic features.
Literatur
1.
Zurück zum Zitat Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics Plast Reconstr Surg 1982;69:412–422PubMed Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics Plast Reconstr Surg 1982;69:412–422PubMed
2.
Zurück zum Zitat Enjolras O, Mulliken JB. Vascular tumors and vascular malformations (new issues) Adv Dermatol 1997;13:375–423PubMed Enjolras O, Mulliken JB. Vascular tumors and vascular malformations (new issues) Adv Dermatol 1997;13:375–423PubMed
3.
Zurück zum Zitat Holden KR, Alexander F. Diffuse neonatal hemangiomatosis Pediatrics 1970;46:411–421PubMed Holden KR, Alexander F. Diffuse neonatal hemangiomatosis Pediatrics 1970;46:411–421PubMed
4.
Zurück zum Zitat Blei F, Orlow SJ, Geronemus R. Multimodal management of diffuse neonatal hemangiomatosis [see comment] J Am Acad Dermatol 1997;37:1019–1021 Blei F, Orlow SJ, Geronemus R. Multimodal management of diffuse neonatal hemangiomatosis [see comment] J Am Acad Dermatol 1997;37:1019–1021
5.
Zurück zum Zitat Lopriore E, Markhorst DG. Diffuse neonatal haemangiomatosis: new views on diagnostic criteria and prognosis Acta Paediatr 1999;88:93–97CrossRefPubMed Lopriore E, Markhorst DG. Diffuse neonatal haemangiomatosis: new views on diagnostic criteria and prognosis Acta Paediatr 1999;88:93–97CrossRefPubMed
6.
Zurück zum Zitat North PE, Waner M, Mizeracki A, Mihm MC Jr. . GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol 2000;31:11–22CrossRefPubMed North PE, Waner M, Mizeracki A, Mihm MC Jr. . GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol 2000;31:11–22CrossRefPubMed
7.
Zurück zum Zitat Boon LM, Burrows PE, Paltiel HJ, Lund DP, Ezekowitz RA, Folkman J, et al. Hepatic vascular anomalies in infancy: a twenty-seven-year experience J Pediatr 1996;129:346–354 Boon LM, Burrows PE, Paltiel HJ, Lund DP, Ezekowitz RA, Folkman J, et al. Hepatic vascular anomalies in infancy: a twenty-seven-year experience J Pediatr 1996;129:346–354
8.
Zurück zum Zitat Boon LM, Enjolras O, Mulliken JB. Congenital hemangioma: evidence of accelerated involution J Pediatr 1996;128:329–335CrossRefPubMed Boon LM, Enjolras O, Mulliken JB. Congenital hemangioma: evidence of accelerated involution J Pediatr 1996;128:329–335CrossRefPubMed
9.
Zurück zum Zitat Berenguer B, Mulliken JB, Enjolras O, Boon LM, Wassef M, Josset P, et al. Rapidly involuting congenital hemangioma: clinical and histologic features Pediatr Dev Pathol 2003;6:495–510 Berenguer B, Mulliken JB, Enjolras O, Boon LM, Wassef M, Josset P, et al. Rapidly involuting congenital hemangioma: clinical and histologic features Pediatr Dev Pathol 2003;6:495–510
10.
Zurück zum Zitat Enjolras O, Mulliken JB, Boon LM, Wassef M, Kozakewich HP, Burrows PE. Noninvoluting congenital hemangioma: a rare cutaneous vascular anomaly Plast Reconstr Surg 2001;107:1647–1654CrossRefPubMed Enjolras O, Mulliken JB, Boon LM, Wassef M, Kozakewich HP, Burrows PE. Noninvoluting congenital hemangioma: a rare cutaneous vascular anomaly Plast Reconstr Surg 2001;107:1647–1654CrossRefPubMed
11.
Zurück zum Zitat Fishman SJ, Burrows PE, Leichtner AM, Mulliken JB. Gastrointestinal manifestations of vascular anomalies in childhood: varied etiologies require multiple therapeutic modalities J Pediatr Surg 1998;33:1163–1167CrossRefPubMed Fishman SJ, Burrows PE, Leichtner AM, Mulliken JB. Gastrointestinal manifestations of vascular anomalies in childhood: varied etiologies require multiple therapeutic modalities J Pediatr Surg 1998;33:1163–1167CrossRefPubMed
12.
Zurück zum Zitat Guttmacher AE, Marchuk DA, White RI Jr. Hereditary hemorrhagic telangiectasia [comment] N Engl J Med 1995;333:918–924CrossRefPubMed Guttmacher AE, Marchuk DA, White RI Jr. Hereditary hemorrhagic telangiectasia [comment] N Engl J Med 1995;333:918–924CrossRefPubMed
13.
Zurück zum Zitat Snyder LH, Doan CA. Is the homozygous form of multiple telangiectasias lethal? J Lab Clin Med 1944;29:1211–1216 Snyder LH, Doan CA. Is the homozygous form of multiple telangiectasias lethal? J Lab Clin Med 1944;29:1211–1216
14.
Zurück zum Zitat Reyes-Mujica M, Lopez-Corella E, Perez-Fernandez L, Cuevas-Schacht F, Carrillo-Farga J. Osler-Weber-Rendu disease in an infant Hum Pathol 1988;19:1243–1246PubMed Reyes-Mujica M, Lopez-Corella E, Perez-Fernandez L, Cuevas-Schacht F, Carrillo-Farga J. Osler-Weber-Rendu disease in an infant Hum Pathol 1988;19:1243–1246PubMed
15.
Zurück zum Zitat Boon LM, Mulliken JB, Vikkula M, Watkins H, Seidman J, Olsen BR, et al. Assignment of a locus for dominantly inherited venous malformations to chromosome 9p. Hum Mol Genet 1994;3:1583–1587 Boon LM, Mulliken JB, Vikkula M, Watkins H, Seidman J, Olsen BR, et al. Assignment of a locus for dominantly inherited venous malformations to chromosome 9p. Hum Mol Genet 1994;3:1583–1587
16.
Zurück zum Zitat Gallione CJ, Pasyk KA, Boon LM, Lennon F, Johnson DW, Helmbold EA, et al. A gene for familial venous malformations maps to chromosome 9p in a second large kindred. J Med Genet 1995;32:197–199 Gallione CJ, Pasyk KA, Boon LM, Lennon F, Johnson DW, Helmbold EA, et al. A gene for familial venous malformations maps to chromosome 9p in a second large kindred. J Med Genet 1995;32:197–199
17.
Zurück zum Zitat Brouillard P, Vikkula M. Vascular malformations: localized defects in vascular morphogenesis Clin Genet 2003;63:340–351CrossRefPubMed Brouillard P, Vikkula M. Vascular malformations: localized defects in vascular morphogenesis Clin Genet 2003;63:340–351CrossRefPubMed
18.
Zurück zum Zitat Koerper MA, Addiego JE, Jr., deLorimier AA, Lipow H, Price D, Lubin BH. Use of aspirin and dipyridamole in children with platelet trapping syndromes J Pediatr 1983;102:311–314PubMed Koerper MA, Addiego JE, Jr., deLorimier AA, Lipow H, Price D, Lubin BH. Use of aspirin and dipyridamole in children with platelet trapping syndromes J Pediatr 1983;102:311–314PubMed
19.
Zurück zum Zitat Braverman IM, Keh A, Jacobson BS. Ultrastructure and three-dimensional organization of the telangiectases of hereditary hemorrhagic telangiectasia J Investig Dermatol 1990;95:422–427CrossRefPubMed Braverman IM, Keh A, Jacobson BS. Ultrastructure and three-dimensional organization of the telangiectases of hereditary hemorrhagic telangiectasia J Investig Dermatol 1990;95:422–427CrossRefPubMed
20.
Zurück zum Zitat Katz HP, Askin J. Multiple hemangiomata with thrombopenia. An unusual case with comments on steroid therapy Am J Dis Child 1968;115:351–357PubMed Katz HP, Askin J. Multiple hemangiomata with thrombopenia. An unusual case with comments on steroid therapy Am J Dis Child 1968;115:351–357PubMed
21.
Zurück zum Zitat Gilon E, Ramot B, Sheba C. Multiple hemangiomata associated with thrombocytopenia: remarks on the pathogenesis of the thrombocytopenia in this syndrome Blood 1959;14:74–79PubMed Gilon E, Ramot B, Sheba C. Multiple hemangiomata associated with thrombocytopenia: remarks on the pathogenesis of the thrombocytopenia in this syndrome Blood 1959;14:74–79PubMed
22.
Zurück zum Zitat Odell JM, Haas JE, Tapper D, Nugent D. Infantile hemorrhagic angiodysplasia Pediatr Pathol 1987;7:629–636PubMed Odell JM, Haas JE, Tapper D, Nugent D. Infantile hemorrhagic angiodysplasia Pediatr Pathol 1987;7:629–636PubMed
23.
Zurück zum Zitat Pierce RN, Dunn L, Knisely AS. Consumptive coagulopathy in utero associated with multiple vascular malformations Pediatr Pathol 1992;12:67–71PubMed Pierce RN, Dunn L, Knisely AS. Consumptive coagulopathy in utero associated with multiple vascular malformations Pediatr Pathol 1992;12:67–71PubMed
24.
Zurück zum Zitat Dabska M. Malignant endovascular papillary angioendothelioma of the skin in childhood. Clinicopathologic study of 6 cases Cancer 1969;24:503–510PubMed Dabska M. Malignant endovascular papillary angioendothelioma of the skin in childhood. Clinicopathologic study of 6 cases Cancer 1969;24:503–510PubMed
25.
Zurück zum Zitat Fanburg-Smith JC, Michal M, Partanen TA, Alitalo K, Miettinen M. Papillary intralymphatic angioendothelioma (PILA): a report of twelve cases of a distinctive vascular tumor with phenotypic features of lymphatic vessels Am J Surg Pathol 1999;23:1004–1010CrossRefPubMed Fanburg-Smith JC, Michal M, Partanen TA, Alitalo K, Miettinen M. Papillary intralymphatic angioendothelioma (PILA): a report of twelve cases of a distinctive vascular tumor with phenotypic features of lymphatic vessels Am J Surg Pathol 1999;23:1004–1010CrossRefPubMed
26.
Zurück zum Zitat North PE, Kahn T, Cordisco MR, Dadras SS, Detmar M, Frieden IJ. Multifocal lymphangioendotheliomatosis with thrombocytopenia: a newly recognized clinicopathological entity Arch Dermatol 2004;140:599–606CrossRefPubMed North PE, Kahn T, Cordisco MR, Dadras SS, Detmar M, Frieden IJ. Multifocal lymphangioendotheliomatosis with thrombocytopenia: a newly recognized clinicopathological entity Arch Dermatol 2004;140:599–606CrossRefPubMed
27.
Zurück zum Zitat Oliver G, Detmar M. The rediscovery of the lymphatic system: old and new insights into the development and biological function of the lymphatic vasculature Genes Dev 2002;16:773–783CrossRefPubMed Oliver G, Detmar M. The rediscovery of the lymphatic system: old and new insights into the development and biological function of the lymphatic vasculature Genes Dev 2002;16:773–783CrossRefPubMed
28.
Zurück zum Zitat Xu H, Edwards JR, Espinosa O, Banerji S, Jackson DG, Athanasou NA. Expression of a lymphatic endothelial cell marker in benign and malignant vascular tumors Hum Pathol 2004;35:857–861CrossRefPubMed Xu H, Edwards JR, Espinosa O, Banerji S, Jackson DG, Athanasou NA. Expression of a lymphatic endothelial cell marker in benign and malignant vascular tumors Hum Pathol 2004;35:857–861CrossRefPubMed
29.
Zurück zum Zitat Dadras SS, North PE, Bertoncini J, Mihm MC, Detmar M. Infantile hemangiomas are arrested in an early developmental vascular differentiation state Mod Pathol 2004;17:1068–1079CrossRefPubMed Dadras SS, North PE, Bertoncini J, Mihm MC, Detmar M. Infantile hemangiomas are arrested in an early developmental vascular differentiation state Mod Pathol 2004;17:1068–1079CrossRefPubMed
30.
Zurück zum Zitat Kahn HJ, Bailey D, Marks A. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi’s sarcoma and a subset of angiosarcomas Mod Pathol 2002;15:434–440CrossRefPubMed Kahn HJ, Bailey D, Marks A. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi’s sarcoma and a subset of angiosarcomas Mod Pathol 2002;15:434–440CrossRefPubMed
Metadaten
Titel
Cutaneovisceral Angiomatosis With Thrombocytopenia
verfasst von
Vinay Prasad
Steven J. Fishman
John B. Mulliken
Victor L. Fox
Marilyn G. Liang
Giannoula Klement
Mark W. Kieran
Patricia E. Burrows
David A. Waltz
Julie Powell
Josée Dubois
Moise L. Levy
Antonio R. Perez-Atayde
Harry P.W. Kozakewich
Publikationsdatum
01.08.2005
Erschienen in
Pediatric and Developmental Pathology / Ausgabe 4/2005
Print ISSN: 1093-5266
Elektronische ISSN: 1615-5742
DOI
https://doi.org/10.1007/s10024-005-1124-2

Weitere Artikel der Ausgabe 4/2005

Pediatric and Developmental Pathology 4/2005 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …